Synergistic Antibacterial Effect of Silver Nanoparticles Combined with Ineffective Antibiotics on Drug Resistant Salmonella typhimurium DT104

Journal of Environmental Science and Health - Part C Environmental Carcinogenesis and Ecotoxicology Reviews

Volumn 33, Issue 3, 2015, Pages 369-384

  McShan, Danielle ^a   Zhang, Ying ^a   Deng, Hua ^a   Ray, Paresh C ^a   Yu, Hongtao ^a  

^a JACKSON STATE UNIVERSITY   (United States)

Author keywords

neomycin penicillin; Salmonella typhimurium DT104; silver nanoparticle; tetracycline

Indexed keywords

ANTIBIOTICS; DRUG DELIVERY; METAL NANOPARTICLES; SILVER COMPOUNDS; SILVER NANOPARTICLES;

ANTI-BACTERIAL ACTIVITY; ANTIBACTERIAL EFFECTS; BACTERIAL BINDING; MULTIDRUG RESISTANTS; NEOMYCIN PENICILLIN; SALMONELLA TYPHIMURIUM; SILVER NANOPARTICLES (AGNPS); TETRACYCLINE;

SALMONELLA;

AMPICILLIN; ANTIBIOTIC AGENT; CHLORAMPHENICOL; NEOMYCIN; PENICILLIN DERIVATIVE; PENICILLIN G SODIUM; SILVER NANOPARTICLE; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; TETRACYCLINE DERIVATIVE; ANTIINFECTIVE AGENT; METAL NANOPARTICLE; SILVER;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL MEMBRANE; CELL SURFACE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG POTENTIATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC50; NONHUMAN; PARTICLE SIZE; QUANTITATIVE ANALYSIS; QUANTITATIVE STUDY; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; CHEMISTRY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; MULTIDRUG RESISTANCE;

BACTERIA (MICROORGANISMS); SALMONELLA TYPHIMURIUM;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; METAL NANOPARTICLES; NEOMYCIN; PENICILLINS; SALMONELLA TYPHIMURIUM; SILVER; TETRACYCLINE;

EID: 84938856217     PISSN: 10590501     EISSN: 15324095     Source Type: Journal    
DOI: 10.1080/10590501.2015.1055165     Document Type: Article

References (49)

1. Wax RG, Lewis K, Salyers AA, Taber H. Bacterial Resistance to Antimicrobials, Second Edition edn. Boca Raton, FL: CRC Press; 2012.
2. WHO. Antimicrobial resistance: global report on surveillance 2014. Geneva, Switzerland: World Health Organization; 2014.
3. Walsh C. Molecular mechanisms that confer antibacterial drug resistance. Nature 2000, 406:775-781.
4. Rice LB. The clinical consequences of antimicrobial resistance. Curr Opin Microbiol 2009, 12:476-481.
5. Dasari TPS, Deng H, McShan D, Yu H. Nanosilver-Based Antibacterial Agents for Food Safety. In: Food Poisoning: Outbreaks, Bacterial Sources and Adverse Health Effects. Edited by Ray PC: Nova Science Publishing; 2014: Chapter 2.
6. Boucher HW, Talbot GH, Bradley JS, Edwards Jr. JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:1-12.
7. Dechet AM, Scallan E, Gensheimer K, Hoekstra R, Gunderman-King J, Lockett J, Wrigley D, Chege W, Sobel J. Outbreak of multidrug-resistant Salmonella enterica serotype typhimurium definitive type 104 infection linked to commercial ground beef, Northeastern United States, 2003-2004. Clin Infect Dis 2006, 42(6):747-752.
8. Mather AE, Reid SW, Maskell DJ, Parkhill J, Fookes MC, Harris SR, Brown DJ, Coia JE, Mulvey MR, Gilmour MW et al. Distinguishable epidemics of multidrug-resistant Salmonella Typhimurium DT104 in different hosts. Science 2013, 341(6153):1514-1517.
9. Poppe C, Smart N, Khakhria R, Johnson W, Spika J, Prescott J. Salmonella typhimurium DT104: a virulent and drug-resistant pathogen. Can Vet J 1998, 39(9):559-565.
10. Threlfall EJ. Epidemic Salmonella typhimurium DT104 - A truly international multiresistant clone. J Antimicrob Chemother 2000, 46(1):7-10.
11. Taylor PW, Stapleton PD, Luzio JP. New ways to treat bacterial infections. Drug Discov Today 2002, 21(7):1086-1091.
12. Zhang Y, Dasari TPS, Deng H, Yu H. Antimicrobial Activity of Gold Nanoparticles and Gold Ions. J Environ Sci Health Part C: Environ Carcinog Ecotoxicol Revs 2015, 33(3).
13. Daima HK, Selvakannan P, Shukla R, Bhargava SK, Bansal V. Fine-tuning the antimicrobial profile of biocompatible gold nanoparticles by sequential surface functionalization using polyoxometalates and lysine. Plos One 2013, 8:e79676.
14. He W, Wamer W, Fu PP, Yin JJ. Enzyme-mimetic effects of gold@platinum nanorods on the antioxidant activity. J Environ Sci Health, Part C: Environ Carcinog Ecotoxicol Revs 2014, 32:186-211.
15. Fu PP, Xia Q, Hwang H-M, Ray PC, Yu H. Mechanism of nanotoxicity - Generation of reactive oxygen species. J Food Drug Anal 2014, 22:64-75.
16. Ray PC, Yu H, Fu PP. Nano gold based sensing of environmental toxin: excitement and challenges. J Environ Sci Health, Part C: Environ Carcinog Ecotoxicol Revs 2011, 29:52-89.
17. Naqvi SZH, Kiran U, Ali MI, Jamal A, Hameed A, Ahmed S, Ali N. Combined efficacy of biologically synthesized silver nanoparticles and different antibiotics against multidrug-resistant bacteria. Int J Nanomedicine 2013, 8:3187-3195.
18. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Coll Interf Sci 2004, 275: 177-182.
19. Singh M, S. S, Prasad S, Gambhir S. Nanotechnology in medicine and antibacterial effect of silver nanoparticles. Dig J Nanomat Biostruct 2008, 3(3):115-122.
20. Chen X, Schluesener HJ. Nanosilver: A nanoproduct in medical application. Toxicol Lett 2008, 176(1):1-12.
21. Sotiriou GA, Pratsinis SE. Antibacterial Activity of Nanosilver Ions and Particles. Environ Sci Technol 2010, 44(14):5649-5654.
22. Faya AM, Balaji K, Girilal M, Yadav R, Kalaichelvan PT, Venketesan R. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria. Nanomedicine 2010, 6(1):103-109.
23. Guzman M, Dille J, Godet S. Synthesis and antibacterial activity of silver nanoparticles against gram-positive and gram-negative bacteria. Nanomed: Nanotech Biol Med 2012, 8(1):37-45.
24. Kvitek L, Vanickova M, Panacek A, Soukupova J, Dittrich M, Valentova E, Prucek R, Bancirova M, Milde D, Zboril R. Initial Study on the Toxicity of Silver Nanoparticles (NPs) against Paramecium caudatum. J Phys Chem C 2009, 113(11):4296-4300.
25. Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomed: Nanotech Biol Med 2007, 3(2):168-171.
26. McShan D, Ray PC, Yu H. Molecular toxicity mechanism of nanosilver. J Food Drug Anal 2014, 22(1):116-127.
27. Ahmad A, Mukherjee P, Senapati S, Mandal D, Khan MI, Kumar R, Sastry M. Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum. Coll Surf B Biointerf 2003, 28(4):313-318.
28. Mala R, Arunachalam P, Sivasankari M. Synergistic bactericidal activity of silver nanoparticles and ciprofloxacin against phytopathogens. J Cell Tissue Res 2012, 12(2):3249-3254.
29. Li P, Li J, Wu C, Wu Q, Li J. Synergistic effect of B-lactam antibiotic combined with silver nanoparticles. Nanotechnology 2005, 16:1912-1917.
30. Morones JR, Camacho A, Holt K, Ramirez JT, Yacaman MJ. The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16:2346-2353.
31. Ghosh S, Patil S, Ahire M, Kitture R, Kale S, Pardesi K, Cameotra SS, Bellare J, Dhavale DD, Jabgunde A et al. Synthesis of silver nanoparticles using Dioscorea bulbifera tuber extract and evaluation of its synergistic potential in combination with antimicrobial agents. Int J Nanomed 2012, 7:483-496.
32. He D, Dorantes-Aranda JJ, Waite TD. Silver nanoparticle algae interactions: oxidative dissolution, reactive oxygen species generation and synergistic toxic effects. Environ Sci Technol 2012, 46:8731-8738.
33. Hwang I, Hwang J, Choi H, Kim K, Lee D. Synergistic effect with silver nanoparticles and its involved mechanisms. J Med Microbiol 2012, 61 1719-1726.
34. Ruden S, Hilpert K, Berditsch M, Wadhwani P, Ulrich AS. Synergistic Interaction between Silver Nanoparticles and Membrane-Permeabilizing Antimicrobial Peptides. Antimicrob Agents Chemother 2009, 53(8):3538-3540.
35. Allahverdiyey A, Kon K, Abamor E, Bairova M, Rafailovich M. Coping with antibiotics resistance: combining nanoparticles with antibiotics and other antimicrobial agents. Expert Rev Anti Infect Ther 2011, 9(11):1035-1052.
36. Basavaraja S, Balaji D, Lagashetty A, Rajasab A, Venkataraman A. Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium semitectum. Mater Res Bull 2008, 43(5):1164-1170.
37. Muthiah B, Stanley S. In vivo toxicity assessment of silver nanoparticles synthesized from marine sponges (Haliclona implexiformis). J Pharm Res 2010, 3(10):2552-2554.
38. Chopra I, Roberts M. Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance. Microbiol Mol Biol Rev 2001, 65(2):232-260.
39. Kaul M, Pilch DS. Thermodynamics of Aminoglycoside-rRNA Recognition: The Binding of Neomycin-Class Aminoglycosides to the A Site of 16S rRNA. Biochemistry 2002, 41:7695-7706.
40. Dufrenoy J, Pratt R. Cytochemical Mechanisms of Penicillin Action V. Comparative Effects of Ribonuclease, Cobra Venom, and Penicillin on Susceptible Bacteria. J Bacteriol 1948, 55(4):525-530.
41. Yocum RR, Rasmussen JR, Strominger JL. The Mechanism of Action of Penicillin: Penicillin acylates the active site of bacillus stearothermophzlus d-alanine carboxypeptidase. J Biol Chem 1980, 255(9):3977-3986.
42. Turkevich J, Stevenson PC, Hiller S. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc 1951, 11:55-75.
43. McShan D, Yu H. DNA damage in human skin keratinocytes caused by multiwalled carbon nanotubes with carboxylate functionalization. Toxicol Ind Health 2012, Epub ahead of print.
44. Connell SR, Tracz DM, Nierhausm KH, Taylor DE. Ribosomal Protection Proteins and Their Mechanism of Tetracycline Resistance. Antimicrob Agents Chemother 2003, 47(12):3675-3681.
45. Udumula V, Ham YW, Fosso MY, Chan KY, Rai R, Zhang J, Li J, Chang CW. Investigation of antibacterial mode of action for traditional and amphiphilic aminoglycosides. Bioorg Med Chem Lett 2013, 23(6):1671-1675.
46. Khan SS, Srivatsan P, Vaishnavi N, Mukherjee A, Chandrasekaran N. Interaction of silver nanoparticles (SNPs) with bacterial extracellular proteins (ECPs) and its adsorption isotherms and kinetics. J Hazard Mater 2011, 192(1):299-306.
47. Reidy B, Haase A, Luch A, Dawson KA, Lynch I. Mechanisms of silver nanoparticle release, transformation and toxicity: a critical review of current knowledge and recommendations for future studies and applications. Materials 2013, 6:2295-2350.
48. Wigginton NS, de Titta A, Piccapietra F, Dobias J, Nesatyy VJ, Suter MJF, Bernier-Latmani R. Binding of Silver Nanoparticles to Bacterial Proteins Depends on Surface Modifications and Inhibits Enzymatic Activity. Environ Sci Technol 2010, 44(6):2163-2168.
49. Baruwati B, Simmons SO, Varma RS, Veronesi B. "Green" synthesized and coated nanosilver alters the membrane permeability of barrier (intestinal, brain endothelial) cells and stimulates oxidative stress pathways in neurons. ACS Sustain Chem Eng 2013, 1:753-759.